Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


Preferences help
enabled [disable] Abstract
Number of results
2025 | 60 | 77-86

Article title

From Tradition to Therapy: Medicinal Plants as a Promising Approach to Atherosclerosis

Content

Title variants

Languages of publication

EN

Abstracts

EN
Atherosclerosis, a major cardiovascular disease, is characterized by the accumulation of fatty streaks and plaques in arterial walls, driven by factors such as inflammation, oxidative stress, and lipid buildup. This review explores the therapeutic potential of medicinal plants as a promising option for preventing and managing atherosclerosis, emphasizing their bioactive compounds that target key disease mechanisms. Plants such as Perovskia abrotanoides, rich in phenolic compounds and essential oils, exhibit antioxidant and anti-inflammatory properties that mitigate oxidative stress and vascular damage. Similarly, widely accessible plants like ginger, turmeric, and garlic offer cardiovascular benefits by reducing inflammation and preventing arterial fat accumulation when incorporated into daily diets. This article extends its focus to additional medicinal plants, including Gundelia tournefortii, Pulicaria gnaphalodes, Valeriana officinalis, Sesamum indicum, Allium ampeloprasum, and Origanum majorana, which demonstrate significant anti-atherosclerotic effects. These plants contribute through diverse mechanisms, such as improving lipid profiles, inhibiting LDL oxidation, enhancing endothelial function, and reducing pro-inflammatory cytokines. The review highlights the limitations of synthetic drugs, including side effects and costs, underscoring the resurgence of interest in natural remedies. By integrating traditional knowledge with modern research, this study elucidates the molecular pathways—such as modulation of lipid metabolism and reduction of foam cell formation—through which these plants act. While preliminary findings are promising, further in vivo studies are needed to validate efficacy and safety. This comprehensive analysis aims to develop strategies for leveraging medicinal plants as viable, accessible options for atherosclerosis management, promoting cardiovascular health and overall wellness.

Discipline

Year

Volume

60

Pages

77-86

Physical description

Contributors

  • Faculty of Science, University of Kashan, Kashan, Iran
  • Faculty of Pharmacy, University of Al-Qadisiyah, Al Diwaniyah, Iraq
author
  • Faculty of Science, University of Kashan, Kashan, Iran
  • Department of Medical Laboratory Technology, College of Medical Technology, The Islamic University, Najaf, Iraq

References

  • [1] Sedighi M, Nazari B, Rafieian-Kopaei M, Bahmani M, Ghaderi S. A review of plant-based compounds and medicinal plants effective on atherosclerosis. J Res Med Sci. 2017; 22(1): 30.
  • [2] McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000; 72(5 Suppl): 1307S–15S.
  • [3] Gholipour S, Bahrami N, Rafieian-Kopaei M, Beyranvand F, Sharifi A. Medicinal plants and atherosclerosis: a review on molecular aspects. Curr Pharm Des. 2018; 24(26): 3123–31.
  • [4] Rashidi B, Mohammadi M, Mirzaei F, Badalzadeh R, Reisi P. Pathophysiology of atherosclerosis. Pathophysiology. 2011; 18(2): 137–42.
  • [5] Setorki M, Nazari B, Asgary S, Azadbakht L, Rafieian-Kopaei M. Anti-atherosclerotic effects of some medicinal plants. Afr J Pharm Pharmacol. 2011; 5(8): 1038–45.
  • [6] Madihi Y, Merrikhi A, Baradaran A, Ghobadi S, Shahinfard N, Ansari R, Karimi A, Mesripour A, Rafieian-Kopaei M. Impact of some medicinal plants on atherosclerosis. Pak J Med Sci. 2013; 29(1 Suppl): 252–6.
  • [7] Ghaderi S, Ebrahimi SN, Ahadi H, Moghadam SE, Mirjalili MH. In vitro propagation and phytochemical assessment of Perovskia abrotanoides Karel. (Lamiaceae) – a medicinally important source of phenolic compounds. Biocatal Agric Biotechnol. 2019; 19: 101111
  • [8] Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006; 47(8 Suppl): C7–12.
  • [9] Libby P. The changing landscape of atherosclerosis. Nature. 2021; 592(7855): 524–33.
  • [10] Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014; 5(8): 927–46.
  • [11] Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135–43.
  • [12] Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A, Martín C. Pathophysiology of atherosclerosis. Int J Mol Sci. 2022; 23(6): 3346.
  • [13] Lusis AJ. Genetics of atherosclerosis. Trends Genet. 2012; 28(6): 267–75.
  • [14] Barnes MJ, Farndale RW. Collagens and atherosclerosis. Exp Gerontol. 1999; 34(4): 513–25.
  • [15] Mohammadhosseini M, Venditti A, Akbarzadeh A. The genus Perovskia Kar.: ethnobotany, chemotaxonomy and phytochemistry: a review. Toxin Rev. 2021; 40(4): 484–505.
  • [16] Ilkaee MN, Hosseini SM, Hosseinzadeh H, Ghaemi EA. Effect of abiotic environmental factors on growth and essential oil characteristics of Perovskia abrotanoides Karel. J Essent Oil Bear Plants. 2017; 20(3): 729–43.
  • [17] Mohammadhosseini M, Sarker SD, Akbarzadeh A. Compositional studies and biological activities of Perovskia abrotanoides Kar. oils. Biol Res. 2014; 47: 1–9.
  • [18] Puormand SM, Hosseinzadeh H, Ghaemi EA. Protective ability of Perovskia abrotanoides Karel root extract on the aggregation of protein in vitro. Nat Prod J. 2020; 10(2): 113–21.
  • [19] Mahboubi M, Kazempour N. The antimicrobial activity of essential oil from Perovskia abrotanoides Karel and its main components. Indian J Pharm Sci. 2009; 71(3): 343–7.
  • [20] Moallem SA, Niapour M. Study of embryotoxicity of Perovskia abrotanoides, an adulterant in folk medicine, during organogenesis in mice. J Ethnopharmacol. 2008; 117(1): 108–14.
  • [21] Tareen RB, Bibi T, Khan MA, Ahmad M, Zafar M. Indigenous knowledge of folk medicine by the women of Kalat and Khuzdar regions of Balochistan, Pakistan. Pak J Bot. 2010; 42(3): 1465–85.
  • [22] Kianasab MR, Hosseinzadeh H, Ghaemi EA, Akbarzadeh A, Venditti A. Screening of the compositions of essential oils and volatiles of Perovskia abrotanoides Karel. along with antioxidant, antibacterial and cytotoxic impacts of its methanol extract. Nat Prod Res. 2023: 38(21), 1–5.
  • [23] Pourhosseini SH, Mirjalili MH, Nejad Ebrahimi S, Ahadi H. Essential oil quantity and quality of different plant organs from Perovskia abrotanoides Karel in natural habitat of North Khorasan province. Plant Prod. 2018; 40(4): 53–62.
  • [24] Mazandarani M, Beykmohammadi M, Bayat H. Ethno pharmacology and investigation secondary metabolites of Perovskia abrotanoides Karel. in two natural regions, North of Iran. J Plant Environ Physiol. 2010; 16: 1–10.
  • [25] Hafez Ghoran S, Azadi B, Hussain H. Chemical composition and antimicrobial activities of Perovskia artemisioides Boiss. essential oil. Nat Prod Res. 2016; 30(17): 1997–2001.
  • [26] Farajtabar F, Ghaemi EA, Hosseinzadeh H. Production of tanshinones and phenolic acids in hairy root cultures of Perovskia abrotanoides Karel. 7rd National Congress on Medicinal Plants; Shiraz, Iran, 2018.
  • [27] Mokhtarshahi V, Abrishamchi P. Antibacterial effect of essential oils from Perovskia abrotanoides Karel against periodontal pathogens, Streptococcus mutans and Streptococcus sanguinis and its relationship with plant phenology. In: 3rd National Congress on Medicinal Plants, Shiraz, Iran, 2014.
  • [28] Sadeghi Z, Valizadeh J, Shermeh OA, Akaberi M. Terpenoid constituents of Perovskia artemisioides aerial parts with inhibitory effects on bacterial biofilm growth. J Nat Prod. 2020; 84(1): 26–36.
  • [29] Elmizadeh A, Goli SAH, Rahimmalek M. Application of cold plasma pretreatment to improve the extraction efficiency of tanshinone compounds from Salvia subg. Perovskia root. Ind Crops Prod. 2023; 204: 117337.
  • [30] Miroliaei M, Khazaei S, Majidi J, Kazemi M. Inhibition of glycation-induced cytotoxicity, protein glycation, and activity of proteolytic enzymes by extract from Perovskia atriplicifolia roots. Pharmacogn Mag. 2017; 13(Suppl 3): S676–81.
  • [31] Shariatifar N. Qualitative and quantitative study of Pulicaria gnaphalodes essential oil and plant extract [Thesis]. Tehran: Tehran University; 2011.
  • [32] Cropley M, Banks AP, Boyle J. Effect of kava and valerian on human physiological and psychological responses to mental stress. Phytother Res. 2002; 16(1): 23–7.
  • [33] Hayakawa H, Raij L. Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension. J Hypertens. 1999; 17(5): 611–9.
  • [34] Lee YS, Kim AY, Choi JM, Kim M, Yasue S, Son HJ, Masaki H, Bae HM, Lim HK, Lee SH, Shin DM, Kim JE, Ahn JH, Lee JH, Kim DH, Kang HH, Kim YH, Kim IH, Yoon HS, Kim JH. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006; 55(8): 2256–64.
  • [35] Ernst E, Resch KL. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 1993; 118(12): 956–63.
  • [36] Wakasugi M, Noguchi T, Inoue M, Tawata M, Onaya T. Effects of aldose reductase inhibitors on prostacyclin (PGI2) synthesis by aortic rings from rats with streptozotocin-induced diabetes. Prostaglandins Leukot Essent Fatty Acids. 1991; 44(4): 233–6.
  • [37] Alma MH, Nitz S, Kollmannsberger H, Digrak M, Efe FT, Yilmaz N. Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey. Biol Pharm Bull. 2003; 26(12): 1725–9.
  • [38] Karagodin VP, Sobenin IA, Orekhov AN. Antiatherosclerotic and cardioprotective effects of time-released garlic powder pills. J Nutr Metab. 2016; 2016: 1–10.
  • [39] Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azen SP. Garlic intake and cardiovascular risk factors: a meta-analysis. J Nutr. 2011; 141(4): 677–84.
  • [40] Mahdavi-Roshan M, Zahedmehr A, Mohammad-Zadeh A, Sanati HR, Shakerian F, Firouzi A, Kiani R, Nasrollahzadeh J. The effects of regular consumption of green or black tea on blood pressure and lipid profile in healthy adults: a randomized controlled trial. J Hum Hypertens. 2013; 27(2): 100–6.
  • [41] Fritsch RM, Keusgen M. Occurrence and taxonomic significance of cysteine sulphoxides in the genus Allium L. (Alliaceae). Phytochemistry. 2006; 67(11): 1127–35.
  • [42] Sheela CG, Kumud K, Augusti KT. Anti-diabetic effects of onion and garlic sulfoxide amino acids in rats. Planta Med. 1995; 61(4): 356–7.
  • [43] Asgary S, Rafieian-Kopaei M, Sahebkar A, Shamsi F, Goli-Malekabadi N. Anti-hyperlipidemic and anti-atherosclerotic effects of Gundelia tournefortii in experimental animals. J Herbmed Pharmacol. 2016; 5(3): 97–101.
  • [44] Namazi N, Tarighat A, Bahrami A. The effect of Pulicaria gnaphalodes on oxidative stress and inflammatory markers in patients with atherosclerosis: a randomized controlled trial. Phytother Res. 2018; 32(7): 1324–30.
  • [45] Sudjaroen Y, Haubner R, Würtele G, Hull WE, Erben G, Spiegelhalder B, Changbumrung S, Owen RW, Bartsch H. Isolation and structure elucidation of phenolic antioxidants from Valeriana officinalis. J Nat Prod. 2005; 68(6): 838–43.
  • [46] Wu HC, Shiau CY, Chen HM, Chiou TK. Antioxidant activities of sesame seed extracts and their inhibitory effects on lipid peroxidation. Food Chem. 2003; 82(4): 599–604.
  • [47] Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutr J. 2002; 1: 4.
  • [48] Bhandari U, Kanojia R, Pillai KK. Anti-atherosclerotic effect of Origanum majorana L. extract in cholesterol-fed rabbits. Indian J Exp Biol. 2007; 45(5): 474–8.
  • [49] Ross R. Atherosclerosis — an inflammatory disease. N Engl J Med. 1999; 340(2): 115–26.
  • [50] Hosseini A, Hosseinzadeh H. A review on the effects of Allium ampeloprasum on cardiovascular risk factors and oxidative stress. J Herb Med. 2019; 17: 100266

Document Type

article

Publication order reference

Identifiers

YADDA identifier

bwmeta1.element.psjd-f863518f-8d00-434d-a5f6-91e04c6d708c
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.